Loading...
•
Jun 26, 2021
Hologic Q3 2021 Earnings Report
Hologic's financial results for Q3 2021 were announced, with revenue increasing by 42.0% and GAAP diluted EPS reported at $1.04.
Key Takeaways
Hologic reported strong financial results for the third quarter of fiscal year 2021, with revenue increasing 42.0% to $1.168 billion and GAAP diluted EPS reaching $1.04. The company finalized the Mobidiag acquisition and experienced growth in its base businesses.
Revenue increased 42.0% for the quarter, or 37.8% in constant currency.
Organic revenue in the third quarter increased 38.4%, or 34.2% in constant currency, excluding material acquisitions and divestitures.
Worldwide diagnostics revenue increased 25.0%, despite lower demand for COVID assays.
The company completed the acquisition of Mobidiag for approximately $808 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For Q4 2021, Hologic anticipates strong growth in base businesses, which will be offset by declines in COVID testing revenue.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...